ICC 2019

Michael Thompson, Speaker at Cancer Congress
Keynote Presentation
Michael Thompson, University of Toronto, Canada

Ovarian cancer is the most deadly gynaecological disease that affects a quarter of a million women annually, resulting in over 140,000 deaths worldwide. Currently, detection of ovarian cancer requires time-consuming imaging techniques such as transvaginal ultrasound and MRI scans [....] » Read More

Sherri J Tenpenny, Speaker at  Oncology Conferences
Keynote Presentation
Sherri J Tenpenny, Tenpenny Integrative Medical Center, United States

Vaccination is said to be a valuable public health tool for preventing infection. However, there are growing concerns over the increased number of reported severe side effects following vaccination. This presentation will discuss the use of immortalized cell lines, the presence o [....] » Read More

Atif A Ahme, Speaker at Oncology Conferences
Keynote Presentation
Atif A Ahme, Children’s Mercy Hospitals and Clinics, United States

Precision oncologic medicine is an emerging approach for cancer treatment that has recently taken giant steps into solid clinical practice. Recent advances in molecular diagnostics that can analyze the individual tumor’s variability in genes have provided greater understand [....] » Read More

Atilla Soran, Speaker at 
Oncology Conference
Oral Presentation
Atilla Soran, University of Pittsburgh Medical Center, United States

The incidence of de novo stage IV breast cancer (BC) is between 5 to 10% and, systemic therapy (ST) is the primary treatment choice. However, more and more studies show that ST may not be the only option. The traditional goal of loco-regional in such cases is to palliate symptoms [....] » Read More

Penny Kechagioglou, Speaker at Cancer Conferences
Oral Presentation
Penny Kechagioglou, GenesisCare, United Kingdom

The Breast Service of the Future is a service transformation project, which aims at combining all elements of excellent cancer care from diagnosis to survivorship. At times of financial and workforce pressures, there should not be any compromise in the quality, efficiency and acc [....] » Read More

Mary K Hayes, Speaker at  Cancer Conferences
Oral Presentation
Mary K Hayes, Memorial Healthcare System, United States

Breast cancer conservative surgical treatment programs rely on the available image guidance devices and skills of the radiologist and surgeon team. Each breast cancer treatment team adopts the most effective localization and margin assessment technique based on the skills and tec [....] » Read More

Luigi Marongiu, Speaker at Cancer Congress
Oral Presentation
Luigi Marongiu, University of Heidelberg, Germany

Virus integration is increasingly indicated in the public domain as a major risk factor in carcinogenesis. Massively parallel sequencing (MPS) has become one of the most popular tools for the identification of viral genomes in human samples and several tools have been designed to [....] » Read More

Pasupathy Kiruparan, Speaker at  Oncology Conferences
Oral Presentation
Pasupathy Kiruparan, Blackpool Victoria Hospital, United Kingdom

Background: Age discrimination in the provision of health and care services was banned in the UK in 2012. However there continue to be age related discrepancies in the prevalence, treatment and outcomes experienced by people with breast cancer. British Association of Day Surgery [....] » Read More

Mercedes Porosnicu, Speaker at Oncology Conferences
Oral Presentation
Mercedes Porosnicu, Wake Forest University School of Medicine, United States

Head and neck squamous cell carcinoma (HNSCC) represents the 5th most common cancer in the world, characterized by poor prognosis. Significant recent therapeutic advances changed the HNSCC brand but superior survival is limited to a small percentage of patients. Promoting novel t [....] » Read More

Saritha Karre, Speaker at Oncology Conference
Oral Presentation
Saritha Karre, ESIC Medical College & Hospital, India

I will be discussing and describing on spectrum of lesions of cervical neoplasia and the utility of cervical cytopathology in detecting the premalignant and malignant lesions. Discussion on the risk of these lesions in different age groups, so that appropriate and preventive meas [....] » Read More

Vicki Vance, Speaker at Cancer Conferences
Oral Presentation
Vicki Vance, University of South Carolina, United States

MicroRNAs (miRNAs) are small noncoding RNAs that comprise an emerging class of therapeutic agents with significant potential for the prevention and treatment of many diseases, including cancer. Many different forms of cancer are associated with loss or reduced accumulation of one [....] » Read More

Urszula Wojda, Speaker at  Cancer Conferences
Oral Presentation
Urszula Wojda, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Poland

One of the major challenges in cancer and Alzheimer’s disease (AD) is identification of early, non-invasive biomarkers and elucidation of their functions. Circulating microRNAs (miRNAs) have been extensively studied as potential biomarkers for cancer and AD. Their profiles [....] » Read More

Zhenlong Ye, Speaker at Cancer Congress
Oral Presentation
Zhenlong Ye, Shanghai Baize Medical Laboratory, China

I mmunotherapies with chimeric antigen receptor-modified T (CAR-T) cells and Immune Checkpoint Inhibitors (ICIs) have shown exhilarative clinical outcome in treating Cancers. When applying CAR-T-based and ICIs-based immunotherapies for treating solid tumors, detection of expressi [....] » Read More

Archana Kumari Redhu, Speaker at Cancer Congress
Oral Presentation
Archana Kumari Redhu, Indian Institute of Technology, India

Cancer cells display enhanced glycolytic activity and impaired oxidative phosphorylation even in the presence of adequate oxygen (Warburg effect). Mitochondrial physiology is a promising hit target for anti-cancer therapy because of its key role in Warburg effect and activating a [....] » Read More

Nusyba Mohamed Ahmed Bushra Mohamed Ahmed, Speaker at  Oncology Conferences
Oral Presentation
Nusyba Mohamed Ahmed Bushra Mohamed Ahmed, University of Medical Sciences and Technology, Sudan

This presentation will discuss the aim of the study; to compare the staining specificity and intensity of Hematoxylin and Eosin (H&E) stain and Modified Papanicolaou stain, to stain the keratin present in Oral Squamous Cell Carcinoma. It will also discuss the methodology used [....] » Read More

Ping Li, Speaker at  Oncology Conferences
Oral Presentation
Ping Li, Tongji University, China

Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a novel treatment modality for B-cell malignancies. CD19-specific CAR-T cells induce high rates of initial response among patients with relapsed B-cell acute lymphoblastic leukemia (ALL). However, cytokine release sy [....] » Read More

Jianhua Luo, Speaker at Oncology Conference
Keynote Presentation
Jianhua Luo, University of Pittsburgh, United States

Chromosome mutations and rearrangements are some of the hallmarks of human malignancies. Chromosomal rearrangement is frequent in human cancers. One of the consequences of chromosomal rearrangement is gene fusions in the cancer genome. We have identified a panel of fusion genes i [....] » Read More

Vladimir Torchilin, Speaker at Cancer Conferences
Keynote Presentation
Vladimir Torchilin, Northeastern University, United States

Pharmaceutical nanocarriers, including liposomes and polymeric micelles, are frequently used for the delivery of a broad variety of both soluble and poorly soluble anticancer drugs to enhance their in vivo efficiency. The next generation of drug delivery systems for cancer, espec [....] » Read More

Mark S Parker, Speaker at Cancer Congress
Keynote Presentation
Mark S Parker, VCU Medical Center, United States

Lung cancer is the leading cause of cancer death for both men and women worldwide, regardless of race and ethnicity. Each year, lung cancer alone claims the lives of more persons than all of the cancers of the breast, prostate, colorectum, kidney and melanoma combined. Historical [....] » Read More

Angus Dalgleish, Speaker at Cancer Congress
Oral Presentation
Angus Dalgleish, St. George’s University of London, United Kingdom

I mmunotherapy has finally been approved as a mainstream modality. Unfortunately, whereas dramatic increases in survival have been achieved, the majority of patients do not yet benefit. It is becoming evident that patients with systematically raised inflammatory markers do not be [....] » Read More

Ramzi M Mohammad, Speaker at Cancer Congress
Oral Presentation
Ramzi M Mohammad, Wayne State University, United States

Nuclear export is an evolutionary conserved mechanism that regulates the balanced nuclear expression of tumor suppressor proteins (TSPs). Overexpression of the major exportin protein chromosome region maintenance 1 (CRM1) results in nuclear exclusion of TSPs and is considered the [....] » Read More

Thomas Becker, Speaker at Cancer Conferences
Oral Presentation
Thomas Becker, Northwest Portland Area Indian Health Board, United States

Relatively few studies of cancer prevention and control or of cancer etiology among American Indians/Alaska Natives (AI/AN) in the United States (US) have included AI/AN investigators. AI/AN investigators in key roles in cancer control projects are needed to more effectively addr [....] » Read More

Francesco Saverio Mennini, Speaker at Oncology Conferences
Oral Presentation
Francesco Saverio Mennini, University of Rome “Tor Vergata”, Italy

Introduction: Cancer represents the disease that, more than others, reduces people’s workability, causing a considerable number of disabled and incapacitated workers. The aim of this study was to estimate indirect costs, and in particular the disability insurance costs indu [....] » Read More

Radek Kucera, Speaker at Oncology Conferences
Oral Presentation
Radek Kucera, University Hospital in Pilsen, Czech Republic

Background: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Its survival rate does not exceed 15 %. The prevalence rates differ based on ethnicity. Higher rates are observed in Asian countries, but its incidence rate has been increasing in the US and Eur [....] » Read More

Urszula Wojda, Speaker at  Cancer Conferences
Oral Presentation
Urszula Wojda, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Poland

Despite recent progress in leukemia pharmacology, particularly in chronic myelogenous leukemia (CML) treated in chronic phase with imatinib, some patients exhibit resistance or intolerance to chemiotherapy. Therefore the search for new therapeutics for leukemias, of improved sele [....] » Read More

Weimin Cai, Speaker at Oncology Conference
Oral Presentation
Weimin Cai, School of Pharmacy of Fudan University, China

Objective: Genetic polymorphisms of drug metabolic enzymes, transporters and target receptors may account for the interindividual variability of unpredictable peripheral neuropathy induced by nab-paclitaxel. This study aims to identify the biomarkers for peripheral neuropathy ind [....] » Read More

Mona Magdy Saber Moawad, Speaker at  Cancer Conferences
Oral Presentation
Mona Magdy Saber Moawad, Cairo University, Egypt

Despite the variant incidence of CRC, among different countries it remains the third most common type of cancer and leading cause of cancer deaths worldwide. Cisplatin, the most common chemotherapy drug used in solid tumor treatment, is used in combination with other drugs to pro [....] » Read More

Yi Li, Speaker at Cancer Congress
Oral Presentation
Yi Li, XiangXue Life Sciences Research Centre, XiangXue Pharmaceutical Co. Ltd, China

T-cell triggering thresholds can be edited by engineered TCR with enhanced affinity. TAEST (TCR affinity enhanced specific T-cells) for NY-ESO-1 was generated, and the TCR had 29 X higher affinity to its antigen vs wild type T-cells and with good (80-90%+) expression. There was g [....] » Read More

Kamla Khalfan Said Al Salmani, Speaker at Cancer Congress
Oral Presentation
Kamla Khalfan Said Al Salmani, Ministry of Health, Oman

High grade Epithelial Ovarian Cancer (HG-EOC) is the most common type of ovarian cancer. The vast majority of patient present with advanced stage disease. Despite the recent advances in the management, almost all patients develop resistance to cytotoxic chemotherapy and the media [....] » Read More

Kenyangi Sofia Safina, Speaker at Oncology Conferences
Oral Presentation
Kenyangi Sofia Safina, African Cancer Control Alliance, Uganda

Introduction: A cancer diagnosis often produces an overwhelming emotional response, including feelings of shock, denial, fear, anxiety, anger, grief, and depression. Because a multitude of medical tests and consultations typically are needed to determine a definitive diagnosis an [....] » Read More

Kallyne Kioko Oliveira Mimura, Speaker at  Oncology Conferences
Poster Presentation
Kallyne Kioko Oliveira Mimura, Federal University of Mato Grosso, Brazil

The prostate is a gland commonly affected by proliferative and inflammatory lesions. As pequi (Caryocar brasilense) has shown therapeutic potential, this project aims to analyse the antiproliferative and anti-inflammatory actions of pequi oil in the ventral prostate of gerbil und [....] » Read More

Wen Li Lin, Speaker at Oncology Conference
Poster Presentation
Wen Li Lin, Chi Mei Medical Center, Taiwan, China

Background: Colorectal cancer is the cancer with the highest prevalence in Taiwan. Care coordination has received increased attention because it critically affects patient safety and care quality across services. Objectives: This paper is a report of a study conducted to examine [....] » Read More

Zhenghuan Fang, Speaker at Cancer Conferences
Poster Presentation
Zhenghuan Fang, Inha University, Korea, Republic of

Head and neck cancers (HNCs) are aggressive and cause sixth cancer-associated mortality in the world. The treatment options including surgery, radiation therapy, and chemotherapy are complex and often recommended in various combined modalities. Current chemotherapies like cisplat [....] » Read More

Pei Hua Wu, Speaker at Cancer Conferences
Poster Presentation
Pei Hua Wu, Chi Mei Medical Center, Taiwan, China

Background: Lymphoma has the highest prevalence among all cancer types in Taiwan. Care coordination has received increased attention because it critically affects patient safety and care quality across services. Objectives: This study examines and evaluates the effect that adopti [....] » Read More

Mohamed Bala, Speaker at  Cancer Congress
Poster Presentation
Mohamed Bala, Hamad Medical Corporation, Qatar

Background: Colorectal cancer is the third most common cancer among men and the second among women worldwide. However, the public awareness regarding colorectal cancer is generally low. Objective: The current study aimed to assess the awareness regarding colorectal cancer risk f [....] » Read More

Noha Hussein Sayed, Speaker at Cancer Congress
Poster Presentation
Noha Hussein Sayed, Cairo University, Egypt

Colorectal cancer (CRC) is the third leading cause of cancer-related mortality. The aetiology of CRC is complex and involves the interaction of genetic and environmental factors. Recently, obesity has emerged as a major environmental risk factor for CRC. However, the mechanisms u [....] » Read More

Roman Hrstka, Speaker at Oncology Conferences
Poster Presentation
Roman Hrstka, Masaryk Memorial Cancer Institute, Czech Republic

The success of cisplatin (cis-[PtCl2(NH3)2]) in cancer therapy started an unflagging interest in development of new drugs based on transition metal complexes. Among other metals, iron and ruthenium complexes play a prominent role. In our previous work we prepared a series of ferr [....] » Read More

Alireza Sheikhi, Speaker at  Oncology Conferences
Poster Presentation
Alireza Sheikhi, Biochem Lab Company, Armenia

Background: Pituitary adenomas imposes burden of morbidity due to hormone hyper secretion and related effects on patients. Molecular mechanism underlying its incidence, development and progression have yet to be elucidated which can provide insights into new and more efficient th [....] » Read More

Young Chan Yoon, Speaker at  Oncology Conference
Poster Presentation
Young Chan Yoon, Inha University, Korea, Republic of

Head and neck cancers (HNCs) are aggressive and cause sixth cancer-associated mortality in the world. The treatment options including surgery, radiation therapy, and chemotherapy are complex and often recommended in various combined modalities. Current chemotherapies like cisplat [....] » Read More

Rossana Berardi, Speaker at  Cancer Congress
Keynote Presentation
Rossana Berardi, Universita Politecnica delle Marche, Italy

I n recent years, thanks to scientific research, the therapeutic options for cancer patients have significantly increased with a significant improvement in prognosis. In addition, the outcome of cancer patients improves if they are treated in centers of reference with high volume [....] » Read More

Jozef Sabol, Speaker at Oncology Conferences
Keynote Presentation
Jozef Sabol, Department of Crisia Management, PACR, Czech Republic

Purpose: The present system of radiation protection quantities, based on recent recommendations and reports presented by ICRP and ICRU, is rather complicated and thus not easily implementable in practice strictly in accordance with their definitions. The paper discusses some diff [....] » Read More

Jens Claus Hahne, Speaker at Oncology Conference
Oral Presentation
Jens Claus Hahne, The Institute of Cancer Research, United Kingdom

MicroRNAs are pivotal regulators for RNA silencing and post-transcriptional regulation of gene expression under physiological as well as pathological conditions. MicroRNAs can be detected in tissues and in most biologic fluids including serum, plasma and urines. Secreted microRNA [....] » Read More

Jehad Zweiri, Speaker at Cancer Conferences
Oral Presentation
Jehad Zweiri, University of Liverpool Medical School, United Kingdom

Cellular based therapeutic approaches for cancer rely on careful consideration of finding the optimal cell to execute the cellular goal of cancer treatment. Cell lines and primary cell cultures have been used in some studies to compare the in vitro and in vivo efficacy of autolog [....] » Read More

Keitly Mensah, Speaker at Cancer Conferences
Oral Presentation
Keitly Mensah, Ceped, France

Background: With 50,000 death every year, cervical cancer is the fourth most common cause of death by cancer in sub-Saharan countries. Due to high risk human papilloma virus (hr-HPV) persistence on the cervix, leading to premalignous lesions, the disease is more frequent among HI [....] » Read More

Sergio Marcelino De Oliveira, Speaker at  Cancer Congress
Oral Presentation
Sergio Marcelino De Oliveira, Federal University of Mato Grosso, Brazil

n this presentation will be discuss the many clinical trials on the use of nutritional supplements and diets to prevent cancer,including prostate cancer. Besides, will be revised a few substances from the cerrado with therapeutic properties already described in the literature. Ho [....] » Read More

Mahmoud maher abdelnaby alrahawy, Speaker at Cancer Congress
Oral Presentation
Mahmoud maher abdelnaby alrahawy, East Suffolk and North Essex NHS Foundation Trust, United Kingdom

Colorectal Cancer (CRC) is a chief cause of mortality globally. While genetic causes contribute for a small proportion of risk factors for this problem, environmental risk is significantly crucial. Among environmental factors are changes of gut microbial composition (dysbiosis). [....] » Read More

Sergio Alexandre Alcantara Dos Santos, Speaker at Oncology Conference
Oral Presentation
Sergio Alexandre Alcantara Dos Santos, Sao Paulo State University UNESP, Brazil

Although the carcinogenesis is frequently linked to genetic background, exposure to environmental risk factors has gained attention as the etiologic agent for several types of cancer. The intrauterine microenvironment has been described as preponderant factor for offspring health [....] » Read More

Kenyangi Sofia Safina, Speaker at Oncology Conferences
Oral Presentation
Kenyangi Sofia Safina, African Cancer Control Alliance, Uganda

Introduction: Difficulties in accessing appropriate accommodation and transport is a well-documented as a major stress factor for cancer patients seeking care at Uganda Cancer Institute (Young, 2010). A recent assessment of the needs of cancer patients at Mbarara University Cance [....] » Read More

Mukasa Eliphaz, Speaker at Oncology Conferences
Oral Presentation
Mukasa Eliphaz, University of the Witwatersrand, South Africa

Background: At present, pharmaceutical researchers are focusing on instantaneous intraoral dispersible technologies as novel drug delivery systems because; they have outstanding advantages over the traditional oral and parenteral routes of drug administration. Some essential natu [....] » Read More

Safa Abdelazim Ahmed Osman, Speaker at Oncology Conferences
Oral Presentation
Safa Abdelazim Ahmed Osman, Alyarmouk College, Sudan

Introduction: In oral squamous cell carcinoma (O.S.C.C) many factors are attributed in the etiology of it including environmental and genetic factors. An important role in the etiology is played by oncogenic viruses. The most commonly implicated viruses in oral squamous cell carc [....] » Read More

Watsapp